Intraoperative concentrations of ofloxacin in serum, bile fluid, and gallbladder wall tissue
- PMID: 2088189
- PMCID: PMC172060
- DOI: 10.1128/AAC.34.12.2354
Intraoperative concentrations of ofloxacin in serum, bile fluid, and gallbladder wall tissue
Abstract
To evaluate concentrations of ofloxacin in serum, bile fluid, and gallbladder wall tissue after intravenous administration, patients greater than or equal to 16 years old diagnosed with acute cholecystitis were randomly assigned to receive ofloxacin (400 mg) intravenously every 12 h or ceftazidime (2 g) intravenously every 8 h. Doses of each regimen were given preoperatively. Serum, bile fluid, and gallbladder wall tissue samples of consecutive patients in the ofloxacin group were obtained intraoperatively. The samples were frozen at -70 degrees C until analyzed by high-pressure liquid chromatography. Twenty-three patients (6 males and 17 females) were evaluated. The mean (+/- the standard deviation) ofloxacin concentrations in serum, bile fluid, and gallbladder wall tissue were 2.9 +/- 2.4 and 6.0 +/- 7.9 micrograms/ml and 3.1 +/- 2.9 micrograms/g, respectively. The mean number of doses each patient received before surgery was 5.3 +/- 3.0, and the mean delta time (time elapsed between last antibiotic administration and when intraoperative samples were obtained) was 9.6 +/- 7.5 h. The mean tissue-to-serum ratio was 1.2 +/- 0.5, and the mean bile-to-serum ratio was 2.3 +/- 1.4. The mean serum ofloxacin concentrations were not statistically different from the concentrations in bile (P = 0.1) and tissue (P = 0.7) at the mean delta time. The study revealed that concentrations of ofloxacin in serum, bile fluid, and gallbladder tissue after intravenous dosing were adequate against susceptible organisms found in the biliary tract.
Similar articles
-
[A study on the concentrations of levofloxacin in the gallbladder tissue and bile of patients].Jpn J Antibiot. 1992 Mar;45(3):253-7. Jpn J Antibiot. 1992. PMID: 1512921 Japanese.
-
[Chemotherapy of biliary tract infections (XXXVII). Excretion into bile and gallbladder tissue levels of levofloxacin and its clinical effect in biliary tract infections].Jpn J Antibiot. 1992 May;45(5):557-68. Jpn J Antibiot. 1992. PMID: 1512942 Japanese.
-
Tissue concentrations of cefepime in acute cholecystitis patients.Ther Drug Monit. 1992 Jun;14(3):220-5. doi: 10.1097/00007691-199206000-00008. Ther Drug Monit. 1992. PMID: 1412608 Clinical Trial.
-
Concentration of cefixime in bile, gallbladder wall and serum after preoperative administration in patients undergoing cholecystectomy.Methods Find Exp Clin Pharmacol. 1990 May;12(4):287-90. Methods Find Exp Clin Pharmacol. 1990. PMID: 2374476
-
Ofloxacin and the gastrointestinal tract: a potential role in the treatment of bacterial enteritis.J Antimicrob Chemother. 1990 Nov;26 Suppl D:45-53. doi: 10.1093/jac/26.suppl_d.45. J Antimicrob Chemother. 1990. PMID: 2286590 Review.
Cited by
-
Ofloxacin clinical pharmacokinetics.Clin Pharmacokinet. 1992 Jan;22(1):32-46. doi: 10.2165/00003088-199222010-00004. Clin Pharmacokinet. 1992. PMID: 1559306 Review.
-
Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.Drugs. 1991 Nov;42(5):825-76. doi: 10.2165/00003495-199142050-00008. Drugs. 1991. PMID: 1723377 Review.
-
Pharmacokinetics and tissue distribution of intravenous ofloxacin for antibiotic prophylaxis in biliary surgery.Clin Drug Investig. 1998;15(6):491-6. doi: 10.2165/00044011-199815060-00005. Clin Drug Investig. 1998. PMID: 18370506
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources